Skip to main content
ZJAMP Group Co., Ltd. logo

ZJAMP Group Co., Ltd. — Investor Relations & Filings

Ticker · 002758 ISIN · CNE100002029 LEI · 3003009OKT32LB5C0T64 Shenzhen Stock Exchange Wholesale and retail trade
Open in API
Filings indexed 1,563 across all filing types
Latest filing 2020-10-08 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 002758

About ZJAMP Group Co., Ltd.

https://www.znjtgf.com

ZJAMP Group Co., Ltd. specializes in the comprehensive distribution and supply chain management of agricultural production materials. The company’s core operations encompass the procurement, storage, and sale of essential inputs, including chemical fertilizers such as urea, potash, and compound fertilizers, as well as pesticides, seeds, and agricultural machinery. Beyond product distribution, the organization provides integrated technical services, modern logistics solutions, and agricultural consultancy to enhance crop yields and farming efficiency. By leveraging an extensive network of distribution centers and service stations, the group facilitates the stable supply of high-quality agricultural resources. Its business model focuses on bridging the gap between manufacturers and end-users through efficient resource allocation and value-added services.

Recent filings

Filing Released Lang Actions
关于公司董事长及部分董事、监事辞职及补选董事、监事候选人的公告
Board/Management Information Classification · 100% confidence The document is an announcement from Zhejiang Huatong Pharmaceutical Co., Ltd. regarding the resignation of the chairman and some directors and supervisors, as well as the nomination of candidates to fill these board and supervisory positions. It details changes in the company's board and supervisory structure, including resignations and nominations, with references to relevant laws and company regulations. There is no financial data, earnings information, or report publication mentioned. The content clearly relates to changes in the company's board and senior management. Therefore, this document fits the category of Board/Management Information (MANG). The document length is short and focused on management changes, not a full report or announcement of a report publication.
2020-10-08 Chinese
关于召开2020年第一次临时股东大会的通知
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a notice for convening the 2020 first extraordinary general meeting of shareholders of Zhejiang Huatong Pharmaceutical Co., Ltd. It details the meeting date, voting procedures, agenda items including election of board members and supervisors, registration methods, and proxy voting instructions. There are no financial statements or results presented, nor is this a transcript or report of the meeting outcomes. The document is a formal announcement to shareholders about the meeting and how to participate and vote. This fits the definition of a Proxy Solicitation & Information Statement (PSI), which provides information to shareholders to solicit votes for meetings.
2020-10-08 Chinese
独立董事关于公司第四届董事会第七次会议相关事项的独立意见
Board/Management Information Classification · 95% confidence The document is an independent directors' opinion on matters related to the company's board meeting, specifically addressing the resignation of the chairman and the nomination of new board members. It references compliance with regulatory rules and company bylaws, and it is dated around a board meeting. The content focuses on board/management changes rather than financial results or other report types. The document length is short and it is not a report or announcement of a report publication. Therefore, it fits best under Board/Management Information (MANG).
2020-10-08 Chinese
第四届董事会第七次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement from Zhejiang Huatong Pharmaceutical Co., Ltd. regarding resolutions passed at the seventh meeting of the fourth board of directors. It includes details about board member resignations, nominations of new non-independent directors, and the scheduling of an extraordinary general meeting. The content focuses on board/management changes and meeting resolutions rather than financial results, audit opinions, or regulatory filings. The document length is about 2931 characters, which is typical for a detailed board meeting resolution announcement. There is no indication of financial statements or earnings data, nor is it a proxy solicitation or voting result announcement. Therefore, the document best fits the category of Board/Management Information (MANG).
2020-10-08 Chinese
第四届监事会第六次会议决议公告
Board/Management Information Classification · 95% confidence The document is an announcement from Zhejiang Huatong Pharmaceutical Co., Ltd. regarding the resolutions of the sixth meeting of the fourth Supervisory Board. It details the nomination of non-employee supervisory candidates due to resignations and includes their biographies. The document is a formal announcement of changes in the supervisory board members, which falls under management or board changes. There is no financial data, earnings information, or report publication mentioned. The content aligns with announcements about changes in the company's board or senior management rather than a full report or other categories.
2020-10-08 Chinese
关于发行股份购买资产暨关联交易事项实施的进展公告
Capital/Financing Update Classification · 95% confidence The document is an announcement from Zhejiang Huatong Pharmaceutical Co., Ltd. regarding the progress of an asset purchase through share issuance and related party transactions. It references regulatory approval from the China Securities Regulatory Commission and mentions ongoing steps to complete the asset restructuring. The document is relatively short (989 characters) and focuses on providing an update on the implementation progress of a major asset restructuring transaction, not the full details or financial statements of the transaction. It is not a full report like an Annual Report or Interim Report, nor is it a call transcript or earnings release. It is a progress announcement related to a capital transaction (issuing shares to purchase assets). Therefore, the most appropriate classification is Capital/Financing Update (CAP).
2020-09-29 Chinese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.